Lista de obras -

A 24-Hour Study of the Hypothalamo-Pituitary Axes in Huntington's Disease.

artículo científico publicado en 2015

A critical evaluation of inflammatory markers in Huntington's Disease plasma.

artículo científico publicado en 2013

A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease

artículo científico publicado en 2008

A-like cells in the rat stomach contain ghrelin and do not operate under gastrin control.

artículo científico publicado en 2001

Abnormal peripheral chemokine profile in Huntington's disease

artículo científico publicado en 2011

Alterations of matrix metalloproteinases in the healthy elderly with increased risk of prodromal Alzheimer's disease

artículo científico publicado en 2010

Analysis of White Adipose Tissue Gene Expression Reveals CREB1 Pathway Altered in Huntington's Disease.

artículo científico publicado en 2015

Antibodies against phosphorylcholine are not altered in plasma of patients with Alzheimer's disease

artículo científico publicado en 2015

Beyond the brain: widespread pathology in Huntington's disease

artículo científico publicado en 2009

CART regulates islet hormone secretion and is expressed in the beta-cells of type 2 diabetic rats

scientific journal article

Cerebrospinal fluid levels of orexin-A are not a clinically useful biomarker for Huntington disease.

artículo científico publicado en 2006

Characterisation of immune cell function in fragment and full-length Huntington's disease mouse models

artículo científico publicado en 2014

Cocaine and amphetamine regulated transcript (CART) in suicide attempters.

artículo científico publicado en 2007

Effect of cholecystokinin-2 receptor blockade on rat stomach ECL cells. A histochemical, electron-microscopic and chemical study

scientific article published on 01 January 2000

Enhanced immune response to MMP3 stimulation in microglia expressing mutant huntingtin

artículo científico publicado en 2016

Euploidy in somatic cells from R6/2 transgenic Huntington's disease mice

artículo científico publicado en 2005

Evaluation of a previously suggested plasma biomarker panel to identify Alzheimer's disease

artículo científico publicado en 2012

Flt3 ligand does not differentiate between Parkinsonian disorders

artículo científico publicado en 2014

Gastrin and the neuropeptide PACAP evoke secretion from rat stomach histamine-containing (ECL) cells by stimulating influx of Ca2+ through different Ca2+ channels

artículo científico publicado en 2001

Ghrelin and motilin are cosecreted from a prominent endocrine cell population in the small intestine.

artículo científico publicado en 2007

HTT-lowering reverses Huntington's disease immune dysfunction caused by NFκB pathway dysregulation

artículo científico publicado en 2014

Hypothalamic-endocrine aspects in Huntington's disease.

artículo científico publicado en 2006

IGF-1 protects against diabetic features in an in vivo model of Huntington's disease.

artículo científico publicado en 2011

Immunomodulation - a disease-modifying avenue for treatment of Huntington's disease?

artículo científico publicado en 2016

Increased levels of hemoglobin and alpha1-microglobulin in Huntington's disease

Increased metabolism in the R6/2 mouse model of Huntington's disease.

artículo científico publicado en 2007

Increased numbers of motor activity peaks during light cycle are associated with reductions in adrenergic alpha(2)-receptor levels in a transgenic Huntington's disease rat model.

artículo científico publicado en 2009

Interleukin-6 is elevated in the cerebrospinal fluid of suicide attempters and related to symptom severity.

artículo científico publicado en 2009

JAK/STAT Signalling in Huntington's Disease Immune Cells.

artículo científico publicado en 2013

Neurohormonal regulation of histamine and pancreastatin secretion from isolated rat stomach ECL cells.

artículo científico publicado en 1997

Neuropeptide Y (NPY) in cerebrospinal fluid from patients with Huntington's Disease: increased NPY levels and differential degradation of the NPY1-30 fragment

artículo científico publicado en 2016

Orexin and psychiatric symptoms in suicide attempters.

artículo científico publicado en 2006

Orexin loss in Huntington's disease.

artículo científico publicado en 2004

Pharmacological analysis of CCK2 receptor antagonists using isolated rat stomach ECL cells

artículo científico publicado en 1999

Physiology of the ECL cells

artículo científico publicado en 1998

Plasma melatonin is reduced in Huntington's disease.

artículo científico publicado en 2014

Progressive alterations in the hypothalamic-pituitary-adrenal axis in the R6/2 transgenic mouse model of Huntington's disease

artículo científico publicado en 2006

Proteomic profiling of plasma in Huntington's disease reveals neuroinflammatory activation and biomarker candidates

artículo científico publicado en 2007

Reduced orexin levels in the cerebrospinal fluid of suicidal patients with major depressive disorder.

artículo científico publicado en 2007

Reduction of GnRH and infertility in the R6/2 mouse model of Huntington's disease

artículo científico publicado en 2005

Serum levels of a subset of cytokines show high interindividual variability and are not altered in rats transgenic for Huntington´s disease

artículo científico publicado en 2010

Skeletal muscle atrophy in R6/2 mice - altered circulating skeletal muscle markers and gene expression profile changes.

artículo científico publicado en 2014

Somatostatin, misoprostol and galanin inhibit gastrin- and PACAP-stimulated secretion of histamine and pancreastatin from ECL cells by blocking specific Ca2+ channels

artículo científico publicado en 2005

Submucosal microinfusion of endothelin and adrenaline mobilizes ECL-cell histamine in rat stomach, and causes mucosal damage: a microdialysis study.

artículo científico publicado en 2003

Testicular degeneration in Huntington disease.

artículo científico publicado en 2007

White Adipose Tissue Browning in the R6/2 Mouse Model of Huntington's Disease

artículo científico publicado en 2016

Lista de obras de

A 24-Hour Study of the Hypothalamo-Pituitary Axes in Huntington's Disease.

A critical evaluation of inflammatory markers in Huntington's Disease plasma.

A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease

A-like cells in the rat stomach contain ghrelin and do not operate under gastrin control.

Abnormal peripheral chemokine profile in Huntington's disease

Alterations of matrix metalloproteinases in the healthy elderly with increased risk of prodromal Alzheimer's disease

Analysis of White Adipose Tissue Gene Expression Reveals CREB1 Pathway Altered in Huntington's Disease.

Antibodies against phosphorylcholine are not altered in plasma of patients with Alzheimer's disease

Beyond the brain: widespread pathology in Huntington's disease

CART regulates islet hormone secretion and is expressed in the beta-cells of type 2 diabetic rats

Cerebrospinal fluid levels of orexin-A are not a clinically useful biomarker for Huntington disease.

Characterisation of immune cell function in fragment and full-length Huntington's disease mouse models

Cocaine and amphetamine regulated transcript (CART) in suicide attempters.

Effect of cholecystokinin-2 receptor blockade on rat stomach ECL cells. A histochemical, electron-microscopic and chemical study

Enhanced immune response to MMP3 stimulation in microglia expressing mutant huntingtin

Euploidy in somatic cells from R6/2 transgenic Huntington's disease mice

Evaluation of a previously suggested plasma biomarker panel to identify Alzheimer's disease

Flt3 ligand does not differentiate between Parkinsonian disorders

Gastrin and the neuropeptide PACAP evoke secretion from rat stomach histamine-containing (ECL) cells by stimulating influx of Ca2+ through different Ca2+ channels

Ghrelin and motilin are cosecreted from a prominent endocrine cell population in the small intestine.

HTT-lowering reverses Huntington's disease immune dysfunction caused by NFκB pathway dysregulation

Hypothalamic-endocrine aspects in Huntington's disease.

IGF-1 protects against diabetic features in an in vivo model of Huntington's disease.

Immunomodulation - a disease-modifying avenue for treatment of Huntington's disease?

Increased levels of hemoglobin and alpha1-microglobulin in Huntington's disease

Increased metabolism in the R6/2 mouse model of Huntington's disease.

Increased numbers of motor activity peaks during light cycle are associated with reductions in adrenergic alpha(2)-receptor levels in a transgenic Huntington's disease rat model.

Interleukin-6 is elevated in the cerebrospinal fluid of suicide attempters and related to symptom severity.

JAK/STAT Signalling in Huntington's Disease Immune Cells.

Neurohormonal regulation of histamine and pancreastatin secretion from isolated rat stomach ECL cells.

Neuropeptide Y (NPY) in cerebrospinal fluid from patients with Huntington's Disease: increased NPY levels and differential degradation of the NPY1-30 fragment

Orexin and psychiatric symptoms in suicide attempters.

Orexin loss in Huntington's disease.

Pharmacological analysis of CCK2 receptor antagonists using isolated rat stomach ECL cells

Physiology of the ECL cells

Plasma melatonin is reduced in Huntington's disease.

Progressive alterations in the hypothalamic-pituitary-adrenal axis in the R6/2 transgenic mouse model of Huntington's disease

Proteomic profiling of plasma in Huntington's disease reveals neuroinflammatory activation and biomarker candidates

Reduced orexin levels in the cerebrospinal fluid of suicidal patients with major depressive disorder.

Reduction of GnRH and infertility in the R6/2 mouse model of Huntington's disease

Serum levels of a subset of cytokines show high interindividual variability and are not altered in rats transgenic for Huntington´s disease

Skeletal muscle atrophy in R6/2 mice - altered circulating skeletal muscle markers and gene expression profile changes.

Somatostatin, misoprostol and galanin inhibit gastrin- and PACAP-stimulated secretion of histamine and pancreastatin from ECL cells by blocking specific Ca2+ channels

Submucosal microinfusion of endothelin and adrenaline mobilizes ECL-cell histamine in rat stomach, and causes mucosal damage: a microdialysis study.

Testicular degeneration in Huntington disease.

White Adipose Tissue Browning in the R6/2 Mouse Model of Huntington's Disease